On this page:Overview Publications Researchers Institutions Open access

ScholarIQanswers from OpenAlex

Ironwood Pharmaceuticals (United States)

InstitutionResearch output, impact & collaborations

Ironwood Pharmaceuticals (United States) is a institution indexed in ScholarIQ from OpenAlex.

What is known about Ironwood Pharmaceuticals (United States)?

ScholarIQrecord summary

Ironwood Pharmaceuticals (United States) is a research organisation in Boston, US. OpenAlex records 519 works and 48,178 citations for it. 171 researchers list it as their most recent affiliation.

How many works does Ironwood Pharmaceuticals (United States) have?

ScholarIQindexed works

Ironwood Pharmaceuticals (United States) has 519 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

See the works listed for Ironwood Pharmaceuticals (United States) →

How many citations does Ironwood Pharmaceuticals (United States) have?

ScholarIQcitation count

Ironwood Pharmaceuticals (United States) has 48,178 citations in the OpenAlex counts ScholarIQ stores.

See the listed works for Ironwood Pharmaceuticals (United States) →

How many researchers are at Ironwood Pharmaceuticals (United States)?

ScholarIQresearcher count

Ironwood Pharmaceuticals (United States) has 171 researchers in the ScholarIQ index.

See the researchers listed on this page →

What is the average h-index at Ironwood Pharmaceuticals (United States)?

ScholarIQavg h-index

Ironwood Pharmaceuticals (United States) has an average h-index of 24.7 in OpenAlex.

Open the OpenAlex record →

What is the ROR of Ironwood Pharmaceuticals (United States)?

ScholarIQror

The ROR for Ironwood Pharmaceuticals (United States) is on the source record.

Open the ROR →

What is the OpenAlex record for Ironwood Pharmaceuticals (United States)?

ScholarIQopenalex

The OpenAlex for Ironwood Pharmaceuticals (United States) is on the source record.

Open the OpenAlex →

Who are the most-cited researchers behind Ironwood Pharmaceuticals (United States)?

ScholarIQtop researchers by citations

Ramesh K. Ramanathan · Pancreatic and Hepatic Oncology Research

467 works31,500 citations

Jennifer S Sherrer · Iron Metabolism and Disorders

1 works103 citations

Charlene H Gothard · Iron Metabolism and Disorders

1 works103 citations

What are the most-cited papers on Ironwood Pharmaceuticals (United States)?

ScholarIQmost cited works

First-in-human phase I study of copanlisib (BAY 80-6946), an intravenous pan-class I phosphatidylinositol 3-kinase inhibitor, in patients with advanced solid tumors and non-Hodgkin's lymphomas

Amita Patnaik, Leonard J. Appleman, Anthony W. Tolcher, Kyriakos P. Papadopoulos, Muralidhar Beeram, Drew Rasco, Glen J. Weiss, Jasgit C. Sachdev, Manpreet Chadha, Maddie Fulk, Samuel Ejadi, James M. Mountz, Michael T. Lotze, Frederico G. S. Toledo, Edward Chu, Michael Jeffers, Carol E. Peña, Chenjing Xia, Stefanie Reif, Isabelle Genvresse, Ramesh K. Ramanathan

Annals of Oncology. 2016237 CitationsOPEN ACCESS

Herceptin and Gemcitabine for Metastatic Pancreatic Cancers That Overexpress HER-2/<i>neu</i>

Howard Safran, David A. Iannitti, Ramesh K. Ramanathan, Jonathan D. Schwartz, Margaret M. Steinhoff, Chris Nauman, Paul J. Hesketh, Ritesh Rathore, Robert A. Wolff, Umadevi Tantravahi, M. A. HUGHES, C. Maia, Terry Pasquariello, Lisa Goldstein, Thomas C. King, James Tsai, T. A. Kennedy

Cancer Investigation. 2004191 Citations

Intravenous iron dextran therapy in patients with iron deficiency and normal renal function who failed to respond to or did not tolerate oral iron supplementation

James C. Barton, Ellen H Barton, Luigi F. Bertoli, Charlene H Gothard, Jennifer S Sherrer

The American Journal of Medicine. 2000103 Citations

How much of the research on Ironwood Pharmaceuticals (United States) is open access?

ScholarIQopen access share

33%OPEN ACCESS

Gold

Green

Hybrid

Bronze

33%

Closed

67%